These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4741605)

  • 1. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy.
    Aitken JM; Hart DM; Lindsay R
    Br Med J; 1973 Sep; 3(5879):515-8. PubMed ID: 4741605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy.
    Aitken JM; Hart DM; Lindsay R; Anderson JB; Smith DA; Wilson GM
    Isr J Med Sci; 1976 Jul; 12(7):607-14. PubMed ID: 972015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of spinal osteoporosis in oophorectomised women.
    Lindsay R; Hart DM; Forrest C; Baird C
    Lancet; 1980 Nov; 2(8205):1151-4. PubMed ID: 6107766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.
    Lindsay R; Hart DM; Aitken JM; MacDonald EB; Anderson JB; Clarke AC
    Lancet; 1976 May; 1(7968):1038-41. PubMed ID: 57448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ovarian sex steroids on bone mineral status in the oöphorectomized rat and in the human.
    Lindsay R; Aitken JM; Hart DM; Purdie D
    Postgrad Med J; 1978; 54 Suppl 2():50-8. PubMed ID: 740581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone response to termination of oestrogen treatment.
    Lindsay R; Hart DM; MacLean A; Clark AC; Kraszewski A; Garwood J
    Lancet; 1978 Jun; 1(8078):1325-7. PubMed ID: 78095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.
    Lindsay R; Hart DM; Purdie D; Ferguson MM; Clark AS; Kraszewski A
    Clin Sci Mol Med; 1978 Feb; 54(2):193-5. PubMed ID: 340117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on the castration osteoporosis in the rat. II. Behavior of bone minerals].
    Hempel E; Günther P; Neumann G; Müller B
    Zentralbl Gynakol; 1978; 100(21):1391-8. PubMed ID: 735544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis after oophorectomy in the mature female rat and the effect of oestrogen and-or progestogen replacement therapy in its prevention.
    Aitken JM; Armstrong E; Anderson JB
    J Endocrinol; 1972 Oct; 55(1):79-87. PubMed ID: 4660851
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin and postmenopausal osteoporosis.
    Leggate J; Farish E; Fletcher CD; McIntosh W; Hart DM; Sommerville JM
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):85-92. PubMed ID: 6362926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiological determination of changes in bone mineral content.
    Lindsay R; Anderson JB
    Radiography; 1978 Jan; 44(517):21-6. PubMed ID: 628711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis, oestrogens and oöphorectomy. A proposed new test of oestrogenic potency.
    Utian WH
    S Afr Med J; 1975 Mar; 49(12):433-6. PubMed ID: 168644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercortisolaemia and lack of skeletal response to oestrogen in postmenopausal women.
    Aitken JM; Hall PE; Rao LG; Hart DM; Lindsay R
    Clin Endocrinol (Oxf); 1974 Apr; 3(2):167-74. PubMed ID: 4837877
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy.
    Genant HK; Cann CE; Ettinger B; Gordan GS
    Ann Intern Med; 1982 Nov; 97(5):699-705. PubMed ID: 6291439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis after oophorectomy for non-malignant disease in premenopausal women.
    Aitken JM; Hart DM; Anderson JB; Lindsay R; Smith DA; Speirs CF
    Br Med J; 1973 May; 2(5862):325-8. PubMed ID: 4704517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term oestrogens for the prevention of post-menopausal osteoporosis.
    Aitken JM; Lindsay R; Hart DM
    Postgrad Med J; 1976; 52 Suppl 6():18-26. PubMed ID: 790355
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effect of long-term oestrogen therapy on trabecular and cortical bone.
    Hosie CJ; Hart DM; Smith DA; Al-Azzawi F
    Maturitas; 1989 Jun; 11(2):137-45. PubMed ID: 2755345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Has low-dosage therapy with the oral contraceptive Ovosiston any effect on glucose tolerance and liver function?].
    Heller H; Canzler E
    Z Gesamte Inn Med; 1970 Oct; 25(20):936-40. PubMed ID: 4106958
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic effects of mestranol in high dosage.
    Carter AC; Slivko B; Feldman EB
    Steroids; 1970 Jul; 16(1):5-13. PubMed ID: 4097239
    [No Abstract]   [Full Text] [Related]  

  • 20. Mineral content of skeletal bones in otosclerosis.
    Jensen KJ; Nielsen HE; Elbrønd O; Hansen HH
    Clin Otolaryngol Allied Sci; 1979 Oct; 4(5):339-42. PubMed ID: 487632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.